Brevan Howard Capital Management »

Agios Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $477k 11k 44.43
2024-06-30 $596k 14k 43.12
2024-03-31 $478k 16k 29.24
2023-12-31 $413k 19k 22.27

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Ftse/xinhua China 25 China Lg-cap Etf Call Option (FXI)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Industrial Select Sect Spdr Indl Call Option (XLI)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Spdr S&p Biotech Etf S&p Biotech (XBI)
KraneShares CSI China Internet ETF Csi Chi Internet Call Option (KWEB)
Energy Select Sector Spdr Energy Call Option (XLE)
Alibaba Group Holding Sponsored Ads (BABA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Brevan Howard Capital Management

Top funds holding Agios Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
Bellevue Group
T. Rowe Price Associates
State Street Corporation
Armistice Capital
Erste Asset Management GmbH
Jpmorgan Chase & Co
Macquarie Group
Dimensional Fund Advisors
Geode Capital Management
Marshall Wace
BVF
Frazier Life Sciences Management

View all funds holding Agios Pharmaceuticals